南美和中美生物加工市场预测至 2031 年 - 区域分析 - 按产品（仪器和耗材及配件）、运营规模（商业运营和临床运营）、工艺（下游生物工艺和上游生物工艺）、应用（单克隆抗体、疫苗、重组蛋白、细胞和基因治疗等）和最终用户（生物制药公司、合同制造组织等）

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)

No. of Pages: 138    |    Report Code: BMIRE00030827    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Bioprocessing Market
Free Sample Buy Now
2023 年，南美和中美生物加工市场价值为 8.9242 亿美元，预计到 2031 年将达到 22.0564 亿美元；预计 2023 年至 2031 年的复合年增长率为 12.0%。

个性化医疗需求激增推动南美和中美生物加工市场发展

医疗保健行业从一刀切到有针对性的方法的转变正在扩大对个性化医疗的需求。精准医疗被认为是解决癌症、神经退行性疾病和罕见遗传病等健康问题最有前途的方法之一。个性化药物生产的创新可能会影响整个行业，而针对小批量生产的一次性技术在蛋白质生物生产中具有潜在的应用，特别是在下游工艺中。个性化和差异化的医疗方法导致对更广泛产品的需求——其中许多产品针对的是相对较小的患者群体。因此，可能需要从根本上改变生物制品的生产和交付方法。精准医疗利用个体的基因组信息为特定适应症提供针对性治疗。罕见病数量的增加增加了对生物制剂和药物的需求，进而推动了个性化医疗的发展。2019 年，FDA 批准了约 12 种个性化药物，用于解决疾病的根本原因，并进一步将精准医疗与临床护理相结合。此外，政府的不断努力正在加强个性化医疗研究活动。例如，2020 年 2 月，美国国家人类基因组研究所 (NHGRI) 宣布建立一个新的精准医疗和基因组学项目。该项目侧重于基因组学和信息学工具的创新，以更好地诊断和治疗疾病。个性化医疗利用遗传学和生物信息学的进步来针对特定患者群体并治疗以前无法治愈的疾病。个性化医疗使用生物加工技术来开发定制疗法。从分离特定细胞到开发针对特定患者的治疗方法，生物加工步骤对于生产针对每个患者的个性化治疗至关重要。因此，个性化医疗需求的不断增长预计将在预测期内为生物加工市场中的参与者提供巨大的增长机会。

南美和中美生物加工市场概览

南美和中美生物加工市场分为巴西、阿根廷和南美和中美其他地区。据估计，在预测期内，巴西将占据该地区的大部分市场份额。市场参与者在研发方面投入巨资，以通过提供创新产品保持竞争优势。此外，当地法规的改善鼓励跨国生物技术公司涉足南美和中美洲国家，制造和商业化其产品。为了实现地域扩张，过去几家全球生物技术公司由于巴西经济不断增长而选择了巴西市场。因此，各种研究活动的激增、医疗保健支出的增加、治疗癌症和自身免疫性疾病的潜力的增强、对生物技术的投资不断增加以及为开发强大的药物组合而增加的研究合作将为南美和中美的生物加工市场在未来几年创造机会。

南美和中美生物加工市场收入及预测至 2031 年（百万美元）

南美和中美生物加工市场细分

南美和中美生物加工市场分为产品、经营规模、流程、应用、最终用户和国家。

根据产品，南美和中美生物加工市场分为仪器和耗材及配件。仪器部分在 2023 年占有较大的市场份额。此外，仪器部分细分为过滤设备、生物反应器、色谱系统、离心机、干燥设备等。此外，生物反应器子部分分为中试规模、全规模和实验室规模。此外，色谱系统子部分细分为液相色谱、气相色谱等。此外，耗材及配件部分细分为试剂、细胞培养基、色谱树脂等。

就运营规模而言，南美和中美生物加工市场分为商业运营和临床运营。商业运营部门在 2023 年占有更大的市场份额。

按工艺，南美和中美生物加工市场分为下游生物工艺和上游生物工艺。下游生物工艺部门在 2023 年占有更大的市场份额。

根据应用，南美和中美生物加工市场分为单克隆抗体、疫苗、重组蛋白、细胞和基因治疗等。单克隆抗体部门在 2023 年占有最大的市场份额。

就最终用户而言，南美和中美生物加工市场分为生物制药公司、合同制造组织和其他。生物制药公司部门在 2023 年占有最大的市场份额。

按国家/地区划分，南美和中美生物加工市场分为巴西、阿根廷和南美和中美洲其他地区。 2023 年，巴西占据了南美和中美生物加工市场的主导份额。

Getinge AB、Thermo Fisher Scientific Inc、Sartorius AG、Corning Inc、Bio-Rad Laboratories Inc、Merck KGaA、3M Co、Eppendorf SE、Agilent Technologies Inc 和 Cytiva US LLC 是南美和中美生物加工市场的一些领先公司。

South & Central America Bioprocessing Strategic Insights

Strategic insights for South & Central America Bioprocessing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-bioprocessing-market-strategic-framework.webp
Get more information on this report

South & Central America Bioprocessing Report Scope

Report Attribute Details
Market size in 2023 US$ 892.42 Million
Market Size by 2031 US$ 2,205.64 Million
Global CAGR (2023 - 2031) 12.0%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 产品
  • 仪器及耗材及配件
By 运营规模
  • 商业运营及临床运营
By 应用
  • 单克隆抗体
  • 疫苗
  • 重组蛋白
  • 细胞和基因治疗
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Getinge AB
  • Thermo Fisher Scientific Inc
  • Sartorius AG
  • Corning Inc
  • Bio-Rad Laboratories Inc
  • Merck KGaA
  • 3M Co
  • Eppendorf SE
  • Agilent Technologies Inc
  • Cytiva US LLC.
    		•
    Get more information on this report

    South & Central America Bioprocessing Regional Insights

    The regional scope of South & Central America Bioprocessing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-bioprocessing-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - South & Central America Bioprocessing Market

    1. Getinge AB
    2. Thermo Fisher Scientific Inc
    3. Sartorius AG
    4. Corning Inc
    5. Bio-Rad Laboratories Inc
    6. Merck KGaA
    7. 3M Co
    8. Eppendorf SE
    9. Agilent Technologies Inc
    10. Cytiva US LLC.
    Frequently Asked Questions
    How big is the South & Central America Bioprocessing Market?

    The South & Central America Bioprocessing Market is valued at US$ 892.42 Million in 2023, it is projected to reach US$ 2,205.64 Million by 2031.

    What is the CAGR for South & Central America Bioprocessing Market by (2023 - 2031)?

    As per our report South & Central America Bioprocessing Market, the market size is valued at US$ 892.42 Million in 2023, projecting it to reach US$ 2,205.64 Million by 2031. This translates to a CAGR of approximately 12.0% during the forecast period.

    What segments are covered in this report?

    The South & Central America Bioprocessing Market report typically cover these key segments-

  • 产品 (仪器及耗材及配件)
  • 运营规模 (商业运营及临床运营)
  • 应用 (单克隆抗体, 疫苗, 重组蛋白, 细胞和基因治疗)

    • What is the historic period, base year, and forecast period taken for South & Central America Bioprocessing Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Bioprocessing Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
    • Who are the major players in South & Central America Bioprocessing Market?

    The South & Central America Bioprocessing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Getinge AB
  • Thermo Fisher Scientific Inc
  • Sartorius AG
  • Corning Inc
  • Bio-Rad Laboratories Inc
  • Merck KGaA
  • 3M Co
  • Eppendorf SE
  • Agilent Technologies Inc
  • Cytiva US LLC.
    • Who should buy this report?

    The South & Central America Bioprocessing Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South & Central America Bioprocessing Market value chain can benefit from the information contained in a comprehensive market report.

    south-and-central-america-bioprocessing-market